The use of cyclophosphamide for clinical marrow transplantation.
D000505:Alopecia / Q000139:chemically induced; D000741:Anemia, Aplastic / Q000628:therapy; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D004231:Diuresis / Q000187:drug effects; D004912:Erythrocytes / Q000276:immunology; D006087:Graft vs Host Reaction / Q000187:drug effects; D006331:Heart Diseases / Q000139:chemically induced; D006650:Histocompatibility Testing; D006689:Hodgkin Disease / Q000628:therapy; D007621:Karyotyping; D007945:Leukemia, Lymphoid / Q000628:therapy; D007948:Leukemia, Monocytic, Acute / Q000628:therapy*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D009336:Necrosis; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D003520:Cyclophosphamide